Inefficiencies in the division of labour in human societies. [PDF]
Diehl C, Preisendörfer P.
europepmc +1 more source
Geological table showing the proposed provisional classification of stratafied rocks for Tasmania, also showing corresponding divisions elsewhere [PDF]
Robert Mackenzie Johnston
openalex +1 more source
A potential tumor suppressor role of PLK2 in glioblastoma
PLK2 was consistently downregulated in GBM tissues. Overexpression of PLK2 in GBM cell lines U87MG and U251 reduced their tumorigenic potential and enhanced cell cycle arrest and apoptosis. Suggesting that PLK2 overexpression could potentially be leveraged as a therapeutic strategy to inhibit tumor progression and enhance apoptosis, providing new ...
Xiangping Xia+5 more
wiley +1 more source
Evaluation of all-for-one tourism development level: Evidence from Xinjiang production and construction corps, China. [PDF]
Cui Y+5 more
europepmc +1 more source
Identification of inhibitors of the Salmonella FraB deglycase, a drug target
A high‐throughput screen was used to identify inhibitors of Salmonella FraB, a drug target. Characterization of top hits (identified after an additional counter screen) revealed that some triazolidines, thiadiazolidines, and triazolothiadiazoles are mixed‐type inhibitors of FraB.
Jamison D. Law+6 more
wiley +1 more source
Variations in the branching pattern of the internal iliac artery and its implications in trauma and surgery - a South Indian cadaveric study. [PDF]
Badagabettu SN, Padur AA, Shetty SD.
europepmc +1 more source
Abstracts of papers presented at the spring meeting of Kyushu Division
openalex +2 more sources
This review highlights how foundation models enhance predictive healthcare by integrating advanced digital twin modeling with multiomics and biomedical data. This approach supports disease management, risk assessment, and personalized medicine, with the goal of optimizing health outcomes through adaptive, interpretable digital simulations, accessible ...
Sakhaa Alsaedi+2 more
wiley +1 more source
Corrigendum to "A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)": [ESMO Open 9 (2024) 103668]. [PDF]
Kang EJ+17 more
europepmc +1 more source